These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 37303053)

  • 1. Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification.
    McKinley BJ; Allen ME; Michels N
    Eur J Med Res; 2023 Jun; 28(1):188. PubMed ID: 37303053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodistributed Toxic Epidermal Necrolysis: Case Report and Review of Current Literature.
    Gaghan LJ; Coates MM; Crouse LN; Miedema J; Mervak JE; Ziemer CM
    JAMA Dermatol; 2022 Jul; 158(7):787-790. PubMed ID: 35507359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: Proposal for a new diagnostic classification of photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Thwala BN; Teixeira N; Zitha E; Mpungose A; Isaacs T; Peter JG; Lehloenya RJ
    Eur J Med Res; 2024 Jan; 29(1):83. PubMed ID: 38287381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
    Lee HY; Tey HL; Pang SM; Thirumoorthy T
    Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure.
    Russomanno K; DiLorenzo A; Horeczko J; Deng M; Cardis M; Petronic-Rosic V; Johnson LS; Pasieka HB
    JAAD Case Rep; 2021 Aug; 14():68-71. PubMed ID: 34277913
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.
    Lee HY; Dunant A; Sekula P; Mockenhaupt M; Wolkenstein P; Valeyrie-Allanore L; Naldi L; Halevy S; Roujeau JC
    Br J Dermatol; 2012 Sep; 167(3):555-62. PubMed ID: 22639874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.
    Rashid M; Rajan AK; Chhabra M; Kashyap A; Chandran VP; Venkataraman R; Nair S; Thunga G
    Seizure; 2022 Nov; 102():36-50. PubMed ID: 36183454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yan Q; Liu X; Lei H; Liu R; Hu Y
    Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Like Lupus Erythematosus.
    Tankunakorn J; Sawatwarakul S; Vachiramon V; Chanprapaph K
    J Clin Rheumatol; 2019 Aug; 25(5):224-231. PubMed ID: 29912772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
    Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
    Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
    Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
    J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
    Zou H; Daveluy S
    Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.